- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Chandra Bhagat Pharma announced it is exempt from certain corporate governance provisions for the quarter ending March 31, 2026. Since the company is listed on the SME Exchange, it falls under an exemption that simplifies its regulatory requirements. This means Chandra Bhagat Pharma is not obliged to submit a Corporate Governance Report for the mentioned quarter. This update provides clarity on the company's compliance status, reflecting a streamlined operational framework typical for SME-listed entities, which is relevant for investors tracking its governance commitments.